Shoni Health Ventures

VOLL Medical Technologies is a company engaged in the development of innovative medical solutions, currently operating in stealth mode. This approach allows the firm to focus on research and development without public scrutiny or competition. While specific products or technologies have not been disclosed, the company's commitment to advancing medical technology indicates a forward-thinking strategy aimed at addressing unmet needs within the healthcare sector. Their operations reflect a dedication to creating impactful solutions, although details on their offerings and target markets remain under wraps as they continue to refine their innovations.

AISAP develops an artificial intelligence-powered point-of-care ultrasound system. This platform streamlines workflows and provides AI-driven interpretations using deep convolutional neural networks for real-time analysis of ultrasound images, enabling clinicians to make better clinical decisions.

Lin Health is an online platform specializing in personalized, science-based programs for managing chronic pain. It connects individuals with experts who provide integrative care plans, focusing on non-opioid treatments and telehealth services.

QuantHealth is a company focused on enhancing drug development through artificial intelligence-based software. This software is designed to conduct patient-centric simulations that accelerate and de-risk the drug development process. By integrating diverse data points from the clinical and drug development landscape, QuantHealth predicts patient responses to both existing and new therapies. This capability allows pharmaceutical and biotechnology firms to explore various scenarios within their clinical trials, optimizing trial designs and improving the likelihood of successful outcomes. Ultimately, QuantHealth's solutions facilitate the discovery of new clinical opportunities and strategies for optimizing drug development.

Founded in 2018, FeelBetter is a healthcare technology company based in Tel Aviv, Israel. It specializes in an AI-powered platform designed to optimize medication management for patients with complex regimens. The platform uses machine learning and health data to identify at-risk individuals, recommend interventions, and integrate with healthcare workflows, aiming to reduce preventable hospitalizations and improve outcomes for older adults and those with chronic conditions.

Append Medical develops a transcatheter left atrial appendage closure system designed to prevent stroke in atrial fibrillation by eliminating the left atrial appendage through tissue invagination and suture-based closure, offering an alternative to implant-based devices. The system is designed for transfemoral delivery and aims to minimize foreign material at the closure site and reduce device-related thromboembolism risk. The company is in pre-clinical in-vivo testing in its development.

Stealth mode

AISAP develops an artificial intelligence-powered point-of-care ultrasound system. This platform streamlines workflows and provides AI-driven interpretations using deep convolutional neural networks for real-time analysis of ultrasound images, enabling clinicians to make better clinical decisions.